An extensive portfolio of generic APIs and intermediates renowned for their quality, safety and supply security
Evonik is one of the world’s leading suppliers of high-quality generic APIs, biocides and intermediates for the pharmaceutical industry. As a global provider for generic APIs, we offer a broad portfolio of keto acids, ingredients such as Chlorhexidine, and various controlled substance APIs. Furthermore, our portfolio of intermediates includes a wide variety of amino acids and derivatives that are used as starting materials for APIs, as well as multiple types of phosphonium salts and boronic acids. All of these generic APIs and ingredients are consistently manufactured to the highest quality standards at trusted cGMP facilities in Europe and Asia. In most cases, we can tailor the purity of each generic API to your specific needs. Contact us for further information anytime. With more than 40 years of expertise in chemistry, biotechnology and purification, and a strong track record of quality and regulatory excellence, we are ready to offer solutions reducing supply chain risk and accelerating your path to market.
We combine the supply of high-quality generic APIs with regulatory excellence and a range of formulation and analytical services
Evonik is one of the world’s largest and most trusted suppliers of APIs to the pharmaceutical industry. Our reputation for quality and supply security has also made us one of the world’s top CMOs for the contract manufacturing of our customer’s own APIs, HPAPIs and advanced intermediates. In addition to product supply, Evonik offers a range of regulatory support for cGMP-products including process validation, the preparation of Drug Master Files, NEPs, NDAs and IND submissions, as well as REACH and biocidal submissions. We have extensive expertise in providing various certifications for countries around the world. An extensive range of required analytical and formulation development services are also available to help validate your methods, conduct stability studies, compare dissolution profiles, and match or improve properties.
Looking for information compiled in one document? Our brochures offer an overview of relevant details in just a few pages.
High-quality generic APIs including keto acids, amino acids, Chlorhexidine and controlled substance APIs
For more than 30 years, Evonik has been the world’s largest producer of keto acids such as Ketosteril® that are used as chemically derived APIs in the treatment of chronic kidney disease. Our keto acid manufacturing sites in Germany and China have earned a strong industry reputation for consistent quality, with extensive stockpiles of necessary materials maintained to further optimize supply chain security. Likewise, we have been a reliable supplier of biocidal products such as Chlorhexidine (CHD), which is listed as an essential medicine by the World Health Organization, for use across Europe and other international regions for more than 20 years. Evonik also provides considerable experience in the manufacture of benzodiazepines, a type of controlled substance API, including Lorazepam and Lormetazepam where EP and USP-compliant grades are available. Other available generic API products include Lisinopril, used as an ACE inhibitor to treat high blood pressure, and Dimercaprol, a treatment for toxic metal poisoning.
In addition to generic APIs, we offer a broad range of intermediates with added value
When it comes to the supply of intermediates that are used to support the chemical synthesis of various generic APIs, Evonik is strongly positioned to serve as a preferred partner. Our broad range of amino acids and related derivatives are widely used as starting materials in the synthesis of APIs such as peptides, antiviral and high blood pressure drugs. Dozens of phosphonium salts and Ylides, which are used in the synthesis of a range of generic APIs including prostaglandins as well as other non-pharmaceutical applications, are available for standard or custom ordering. We also offer a variety of boronic acids, which are used as intermediates for APIs used in therapeutic areas like oncology.